$RMD

Michael J. Farrell

ResMed

Chairman & CEO • Since 2013 • Health Care

📊 CEO Reputation Score

FY2026 vs FY2025 · Source: SEC EDGAR filings

45/100

Blend of this company's year-over-year free-cash-flow and profit improvement, each ranked as a percentile against every scored company in the three indexes.

Free cash flow: $1.7B → $1.6B (−0.7% YoY) — fiscal 2026 vs fiscal 2025
Profit (net income): $1.4B → $1.5B (+8.8% YoY) — fiscal 2026 vs fiscal 2025

How this score works · S&P 500 reputation leaderboard

Overview

Michael J. Farrell is the chairman & ceo of ResMed since 2013. ResMed is a Health Care company headquartered in San Diego, California, founded in 1989, and one of the 500 companies in the S&P 500 — every one of which is profiled on this site.

Leadership

Michael holds the chief executive role at ResMed with the title Chairman & CEO — in post since 2013. This page is the concise leadership record for ResMed in the S&P 500 CEO index; the site's fully researched long-form profiles (career timelines, education, achievements, setbacks, philosophy and sourced quotes) currently cover the index's ten largest companies, and this entry will be expanded in the same format.

At a Glance

Sector: Health Care
Ticker: $RMD
Headquarters: San Diego, California
Founded: 1989
CEO since: 2013
Index: S&P 500 (#389 of 500)